Cargando…

Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects

The plasminogen activator inhibitor-1 4G/5G and tissue plasminogen activator Alu-repeat insertion/deletion polymorphisms might be genetic determinations of increased or decreased of their plasma activities. The aim of this study was to investigate the association of plasminogen activator inhibitor-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Hamodi, Zaid H., Saif-Ali, Riyadh, Ismail, Ikram S., Ahmed, Khaled A., Muniandy, Sekaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334369/ https://www.ncbi.nlm.nih.gov/pubmed/22573918 http://dx.doi.org/10.3164/jcbn.11-48

Ejemplares similares

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2012)

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2011)

IGF2BP2 Alternative Variants Associated with Glutamic Acid Decarboxylase Antibodies Negative Diabetes in Malaysian Subjects
por: Salem, Sameer D., et al.
Publicado: (2012)

KCNQ1 Haplotypes Associate with Type 2 Diabetes in Malaysian Chinese Subjects
por: Saif-Ali, Riyadh, et al.
Publicado: (2011)

Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016)

Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study
por: Salem, Sameer D, et al.
Publicado: (2014)

Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2015)

Lack of evidence for intermolecular epistatic interactions between adiponectin and resistin gene polymorphisms in Malaysian male subjects
por: Lau, Cia-Hin, et al.
Publicado: (2012)

Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects
por: Jayapalan, Jaime J., et al.
Publicado: (2010)

N(ε)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status
por: Ahmed, Khaled A., et al.
Publicado: (2009)

Role of N(ε)-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
por: A. Ahmed, Khaled, et al.
Publicado: (2007)

Pregnancy-Induced Hypertension and Preeclampsia: Levels of Angiogenic Factors in Malaysian Women
por: Yelumalai, Suseela, et al.
Publicado: (2010)

Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma
por: Mossböck, Georg, et al.
Publicado: (2008)

The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough
por: Tang, Rui, et al.
Publicado: (2023)

Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus
por: Al-Hamodi, Zaid, et al.
Publicado: (2014)

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower
por: Dayco, John, et al.
Publicado: (2022)

Association between Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Sepsis: A Meta-Analysis
por: Li, Li, et al.
Publicado: (2013)

Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review
por: Morgan, Jessie A., et al.
Publicado: (2013)

Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss
por: Li, Xuejiao, et al.
Publicado: (2015)

Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension
por: Wang, Ziran, et al.
Publicado: (2023)

F(2)-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: a Review
por: Kaviarasan, Subramanian, et al.
Publicado: (2009)

The −675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis
por: Nie, Wei, et al.
Publicado: (2012)

Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
por: Zhang, Tengyue, et al.
Publicado: (2013)

The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease
por: Katko, Monika, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1 4G/5G polymorphism and dyslipidemia with branch retinal artery occlusion in a young lady
por: Kurtul, Bengi Ece, et al.
Publicado: (2020)

Ethnic Variation in Interleukin-6 –174 (G/C) Polymorphism in the Malaysian Population
por: Gan, G-G, et al.
Publicado: (2013)

Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis
por: Li, Yan-yan
Publicado: (2012)

Association of the 4 g/5 g polymorphism of plasminogen activator inhibitor-1 gene with sudden sensorineural hearing loss. A case control study
por: Cho, Seong Ho, et al.
Publicado: (2012)

Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
por: Song, J., et al.
Publicado: (2000)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
por: Wang, Yongjie, et al.
Publicado: (2014)

Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis
por: Zhang, Xin, et al.
Publicado: (2020)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
por: Yusoff, Ahmad Faudzi, et al.
Publicado: (2021)

LEP G2548A polymorphism is associated with increased serum leptin and insulin resistance among T2DM Malaysian patients
por: Ali, Layth Ahmed, et al.
Publicado: (2022)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects
por: Ramachandran, Vasudevan, et al.
Publicado: (2009)

Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population
por: Joksic, Ivana, et al.
Publicado: (2020)

Enhanced Expression of Sodium Hydrogen Exchanger (NHE)-1, 2 and 4 in the Cervix of Ovariectomised Rats by Phytoestrogen Genistein
por: Ismail, Nurain, et al.
Publicado: (2015)

Novel adiponectin-resistin (AR) and insulin resistance (IR(AR)) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study
por: Lau, Cia-Hin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kunt9nv1l693b5j3k9vnm6ol05